# A Durable Response in Sinonasal Undifferentiated Carcinoma Treated With Subtotal Resection and Ultra-Early Postoperative Chemoradiotherapy: A Case Report

**Authors:** Kota Hiraoka, Shingo Umemoto, Kaori Tateyama, Takashi Hirano

PMC · DOI: 10.7759/cureus.99738 · Cureus · 2025-12-20

## TL;DR

A 68-year-old man with advanced sinonasal undifferentiated carcinoma achieved long-term remission after subtotal surgery followed by early chemoradiotherapy.

## Contribution

This case report demonstrates durable disease control using ultra-early postoperative chemoradiotherapy after subtotal resection for SNUC.

## Key findings

- A patient with stage IV SNUC achieved complete response after subtotal resection and ultra-early chemoradiotherapy.
- No evidence of recurrence was observed at six-year follow-up.
- Early chemoradiotherapy may offer benefit when gross total resection is not feasible.

## Abstract

Sinonasal undifferentiated carcinoma (SNUC) is a rare and aggressive malignancy that arises in the nasal cavity and paranasal sinuses. Although gross total resection (GTR) is associated with improved local control and survival, the anatomical complexity and frequent skull base invasion often render complete resection infeasible. In such cases, the timing of postoperative therapy may be critical for disease control. We report a case of a 68-year-old man with stage IV SNUC who underwent subtotal endoscopic resection, followed by ultra-early postoperative concurrent chemoradiotherapy (CCRT) initiated within one week of surgery. CCRT was delivered using intensity-modulated radiation therapy (IMRT) and cisplatin (CDDP). The patient achieved a complete response with no evidence of recurrence at six-year follow-up. This case underscores the potential for durable disease control through timely multimodal therapy in anatomically unresectable cases where GTR is not feasible. While GTR remains the optimal goal when achievable, early postoperative chemoradiotherapy may offer meaningful benefit in selected patients with subtotal resection. We discuss the significance of treatment timing, surgical extent, and multidisciplinary planning in the context of recent literature.

## Linked entities

- **Chemicals:** cisplatin (PubChem CID 5460033), CDDP (PubChem CID 5460033)
- **Diseases:** Sinonasal undifferentiated carcinoma (MONDO:0006411), SNUC (MONDO:0006411)

## Full-text entities

- **Diseases:** SNUC (MESH:C537344), malignancy (MESH:D009369)
- **Chemicals:** CDDP (MESH:D002945)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12816408/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12816408/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12816408/full.md

---
Source: https://tomesphere.com/paper/PMC12816408